What this means
PURPOSE OF REVIEW: This narrative review summarizes the current evidence on regenerative peptides relevant to chronic pain management, including collagen peptides, body protection compound-157 (BPC-157), thymosin beta-4 (TB-4), thymosin beta-500 (TB-500), glycyl-L-histidyl-L-lysine copper (GHK-Cu), growth hormone-related peptides, and cibinetide (ARA-290). We review their proposed mechanisms of action, potential clinical applications, preclinical and clinical evidence, safety profiles, and regulatory status.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- People
- Kind of research
- A summary of earlier studies
The science
- Original title
- Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
- Authors
- Luansritisakul C, Chiang MC, Burns SL et al.
- Journal
- Current pain and headache reports
- Published
- Aug 24, 2026
- Study type
- Review · in humans
- PMID
- 42635865 ↗
Abstract
PURPOSE OF REVIEW: This narrative review summarizes the current evidence on regenerative peptides relevant to chronic pain management, including collagen peptides, body protection compound-157 (BPC-157), thymosin beta-4 (TB-4), thymosin beta-500 (TB-500), glycyl-L-histidyl-L-lysine copper (GHK-Cu), growth hormone-related peptides, and cibinetide (ARA-290). We review their proposed mechanisms of action, potential clinical applications, preclinical and clinical evidence, safety profiles, and regulatory status. RECENT FINDINGS: Chronic pain imposes a substantial global burden, yet conventional management strategies often fail to achieve durable, long-term outcomes and primarily focus on symptom control. Regenerative medicine has emerged as a promising alternative by targeting tissue repair and restoration. Among the various therapeutic approaches within regenerative medicine, peptide-based therapies have gained significant attention in recent decades, with growing evidence supporting the efficacy of these interventions. Despite their therapeutic potential, evidence regarding the role of regenerative peptides in chronic pain management remains limited. By synthesizing the available literature, this review aims to provide an evidence-based framework for understanding the potential role of these therapeutic peptides in chronic pain management. However, because most of these therapies remain unapproved by the U.S. Food and Drug Administration (FDA) and clinical evidence in humans is limited, their use should be guided by careful clinical judgment and ongoing evaluation of emerging evidence.
Luansritisakul C, Chiang MC, Burns SL et al. Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management. Current pain and headache reports. 2026. doi:10.1007/s11916-026-01542-z. PMID: 42635865. https://pubmed.ncbi.nlm.nih.gov/42635865/
Related research
Home exercise may change muscle in people with kidney disease
A small trial found changes in muscle blood vessels and fewer fibrosis-linked cells after 12 weeks of home exercise. Only 25 people took part, so this does not prove the exercise caused lasting muscle benefits.
Protein NEDD4 may protect disc cells from aging and cell death in a lab test
Researchers grew disc cells in a dish with an inflammation signal. Boosting NEDD4 eased aging and cell death, and it broke down another protein called PTEN. More tests in living animals and more checks are still needed.
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome.
BACKGROUND: Diabetic foot syndrome (DFS) is characterized by chronic inflammation, thrombotic imbalance, and impaired wound healing, yet systemic molecular alterations underlying this complication remain incompletely…
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
A modified form of thymosin beta 4 helped heart tissue after heart attack in animals
Researchers changed a protein so it stays in the body longer and tested it for heart attack damage. This study was done in animals, so it does not show the same effect in people.
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
See all research on GHK-Cu (copper peptide) →